Pharma funds can deliver high returns due to steady demand in healthcare.
These funds carry high risk as they focus on one sector only.
Long-term holding improves the chances of stable and better returns.
Pharma mutual funds invest money in companies that work in medicine, hospitals, and healthcare services. These funds focus on only one sector, so risk stays high. At the same time, returns can also grow fast when the sector performs well.
The healthcare sector in India shows strong demand due to population growth and rising health needs. These factors support decent long-term returns for pharma funds. On average, these funds have delivered around 13%-14% yearly return in the last five years, with even higher gains in some periods.
These funds suit investors who want high growth and can handle market volatility.
The pharma sector grows due to constant demand. People are always in need of medicines and hospital care. This makes the sector strong even during slow economic phases.
Many Indian pharma companies export drugs to other countries. This helps profits rise. When company profits rise, fund returns also rise.
Another reason is innovation. New drugs, research, and global demand push growth and offer strong 3-year and 5-year returns. Some funds have even crossed 20% yearly return in 3 years.
This is one of the oldest and most popular pharma funds in India. It has a large asset size of around Rs. 7,898 crore. The fund shows stable long-term performance.
Recent data shows:
NAV: Rs. 565.46
1-Month Return: 1.53%
3-Month Return: 3.80%
1-Year Return: 3.30%
3-Year Return: 22.53%
This fund also gave around 14%-16% returns in 5 years. It invests mostly in strong pharma companies.
This fund focuses on pharma, hospitals, and diagnostic companies. It has strong growth in recent years.
Data shows:
NAV: Rs. 41.93
AUM: Rs. 6,293 crore
1-Month Return: 3.97%
3-Month Return: 3.33%
1-Year Return: 5.56%
3-Year Return: 27.02%
This fund stands among the top performers with over 28% return in 3 years.
This fund is newer compared to others but shows fast growth in a short time.
Data shows:
NAV: Rs. 18.38
AUM: Rs. 1,976 crore
1-Month Return: 4.96%
3-Month Return: 8.59%
1-Year Return: 13.20%
Since the fund is new, long-term data is still limited. Still, early performance looks strong.
Also Read - Best Value Mutual Funds to Keep an Eye on in April 2026
This fund balances investment between pharma companies and healthcare services.
Data shows:
NAV: Rs. 34.72
AUM: Rs. 1,229 crore
1-Month Return: 3.12%
3-Month Return: 2.55%
1-Year Return: 2.69%
3-Year Return: 23.28%
It also delivered around 17% returns in 5 years, which shows steady growth.
This fund has a moderate size and consistent performance.
Data shows:
NAV: Rs. 34.32
AUM: Rs. 858 crore
1-Month Return: 1.63%
3-Month Return: 4.83%
1-Year Return: 5.34%
3-Year Return: 24.00%
This fund gave around 14%+ returns in 5 years.
This is a new fund with a smaller asset size. It aims to capture future growth in healthcare.
Data shows:
NAV: Rs. 14.39
AUM: Rs. 556 crore
1-Month Return: 1.85%
3-Month Return: 6.44%
1-Year Return: 10.25%
Since it is new, long-term return data is not available.
This fund is also new and focuses on emerging pharma companies.
Data shows:
NAV: Rs. 16.91
AUM: Rs. 211 crore
1-Month Return: 3.64%
3-Month Return: 5.49%
1-Year Return: -0.89%
3-Year Return: 20.93%
Despite a short-term drop, the 3-year return looks strong.
This fund follows the pharma index instead of active stock selection.
Data shows:
NAV: Rs. 17.35
AUM: Rs. 104 crore
1-Month Return: -0.49%
3-Month Return: 4.05%
1-Year Return: 5.33%
3-Year Return: 21.19%
Index funds usually have lower costs and stable performance.
Many pharma funds have given strong returns over time. For example:
SBI Healthcare Opportunities Fund gave around 24.85% return in 3 years.
ICICI Pharma fund gave around 16%–20% return in 5 years.
Nippon India Pharma Fund delivered around 22% return in 3 years.
These numbers show that pharma funds can generate high returns in the medium to long term.
Pharma funds carry a high risk because they invest in one sector only. If the pharma sector faces a slowdown, returns may fall.
Short-term returns can change quickly. Some funds show negative returns in short periods. This does not mean poor performance in the long term.
Experts suggest a minimum investment period of 5 years or more to reduce risk.
Also Read - Best Large and Mid Cap Mutual Funds in India for April 2026
These funds suit investors who want high growth and can handle market changes. They also suit those who already have diversified investments and want extra exposure to healthcare. Beginners should avoid investing all their money in a single sector fund. A balanced approach helps reduce risk.
Pharma mutual funds in India show strong return potential due to constant demand in healthcare. Funds like Nippon India Pharma Fund, ICICI Prudential Pharma Fund, and Tata Pharma Fund have delivered strong 3-year and 5-year returns.
At the same time, these funds carry high risk due to sector focus. Long-term investment and patience play a key role in success. With proper planning, pharma mutual funds can become a powerful part of a growth-focused investment portfolio.
What are pharma mutual funds?
These funds invest in pharmaceutical and healthcare companies. They mainly include stocks of drug manufacturers, hospitals, diagnostics firms, and biotech companies. Their performance depends on sector-specific factors like innovation, regulations, and global healthcare demand.
Are pharma funds safe?
Risk stays high because the investment focuses on one sector. Any negative news, like regulatory issues, pricing pressure, or failed drug trials, can impact returns. However, diversification within the healthcare space can slightly reduce overall risk compared to single stocks.
What is the ideal investment period?
At least five years helps manage market ups and downs. A longer horizon allows investors to benefit from sector cycles and growth in healthcare demand. Short-term volatility is common, so patience is important to see meaningful returns.
Do these funds give high returns?
Yes, many funds show strong 3-year and 5-year returns. The pharma sector can outperform during certain periods, especially during healthcare-driven demand spikes. However, returns are not consistent every year and depend on market conditions and company performance.
Who should invest in pharma funds?
Investors who accept risk and seek high growth can consider them. They are suitable for those who want exposure to the healthcare sector as part of a diversified portfolio. It is ideal for investors who understand sector trends and can stay invested during volatile phases.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be risky, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here.